• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复方丹参滴丸对2型糖尿病患者颈动脉内膜中层的影响

[Effect of compound Danshen Dripping Pill on carotid arterial intima-media in patients with type 2 diabetes mellitus].

作者信息

Ma Rong-Wei, Zou Da-jin, Wang Qi-jin

机构信息

Department of Endocrinology, Shanghai Changhai Hospital, Shanghai.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Aug;30(8):833-7.

PMID:21038652
Abstract

OBJECTIVE

To investigate the effect of compound Danshen Dripping Pill (DSP) on carotid arterial intima-media thickness (IMT) in patients with type 2 diabetes mellitus (T2DM).

METHODS

One hundred and thirty T2DM patients were assigned to four groups, 32 in the Group A, the control group treated with blood glucose (BG) and blood pressure (BP) controlling; 32 in the Group B, with BG, BP and blood lipid (BL) controlling, 32 in Group C with BG, BP, BL controlling and vitamin E administration, and 34 in Group D with BG, BP, BL controlling and DSP administration. Patients in Group D were subdivided by Chinese medicine syndrome differentiation into four types, 8 of Yin-deficiency with flourishing heat type (YDFH), 5 of both qi-yin deficient type (BQYD), 8 of both yin-yang deficient type (BYYD) and 13 of blood-stasis and qi-stagnant type (BSQS). Fasting blood glucose (FBG), BP and BL in patients were observed periodically, and IMT in them were measured by ultrasonography before treatment, as well as at the end of the 1st, 3rd, and 5th year of treatment to dynamically observe the changes of IMT and condition of plaque formation, and analyze the relation between them with FBG, BP and BL.

RESULTS

The 5-year follow-up was performed in 105 patients. In the observation period, level of total cholesterol (TC) showed a decreasing trend and level of high density cholesterol (HDL-C) showed an increasing trend in all the 4 groups, the improvements in Group C and D were slightly better than those in Group B, while significantly superior to those in Group A; the changes of FBG and glycosylated hemoglobin (HbAlc) were insignificant in the 4 groups. IMT and numbers of atheroma plaque increased gradually in all groups in the observation period, however, the changes in Group D were lesser than those in other groups, showing significant difference (P < 0.01). It was showed that the increasing of cervical carotid IMT in T2DM patients was correlated with levels of HbAlc, HDL-C, LDL-C, triglyceride and TC, especially in Group D.

CONCLUSION

DSP might delay the occurrence and development of diabetic macro-vascular disease.

摘要

目的

探讨复方丹参滴丸(DSP)对2型糖尿病(T2DM)患者颈动脉内膜中层厚度(IMT)的影响。

方法

将130例T2DM患者分为4组,A组32例,为血糖(BG)及血压(BP)控制的对照组;B组32例,进行BG、BP及血脂(BL)控制;C组32例,在BG、BP、BL控制的基础上给予维生素E;D组34例,在BG、BP、BL控制的基础上给予DSP。D组患者按中医辨证分为4型,阴虚热盛型(YDFH)8例,气阴两虚型(BQYD)5例,阴阳两虚型(BYYD)8例,血瘀气滞型(BSQS)13例。定期观察患者的空腹血糖(FBG)、BP及BL,并于治疗前及治疗第1、3、5年末采用超声检查测量IMT,动态观察IMT变化及斑块形成情况,分析其与FBG、BP及BL的关系。

结果

105例患者进行了5年随访。观察期间,4组患者总胆固醇(TC)水平呈下降趋势,高密度胆固醇(HDL-C)水平呈上升趋势,C组和D组改善情况略优于B组,显著优于A组;4组患者FBG及糖化血红蛋白(HbAlc)变化不明显。观察期间,各组IMT及动脉粥样斑块数量均逐渐增加,但D组变化小于其他组,差异有统计学意义(P<0.01)。结果表明,T2DM患者颈总动脉IMT增加与HbAlc、HDL-C、低密度脂蛋白胆固醇(LDL-C)、甘油三酯及TC水平有关,尤其在D组。

结论

DSP可能延缓糖尿病大血管病变的发生与发展。

相似文献

1
[Effect of compound Danshen Dripping Pill on carotid arterial intima-media in patients with type 2 diabetes mellitus].复方丹参滴丸对2型糖尿病患者颈动脉内膜中层的影响
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Aug;30(8):833-7.
2
[Effect of compound danshen dripping pill on arterial intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus].复方丹参滴丸对新诊断2型糖尿病患者动脉内膜中层厚度的影响
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Dec;30(12):1265-8.
3
[Atherogenic index of plasma is associated with carotid intima-media thickness in patients with type 2 diabetes mellitus].血浆致动脉粥样硬化指数与2型糖尿病患者的颈动脉内膜中层厚度相关
Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Sep;35(5):696-8, 707.
4
Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.北印度2型糖尿病患者的餐后高甘油三酯血症与颈动脉内膜中层厚度
Diabetes Res Clin Pract. 2005 Aug;69(2):142-50. doi: 10.1016/j.diabres.2004.11.012.
5
Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.血清高敏C反应蛋白与2型糖尿病患者的颈动脉内膜中层厚度相关。
Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S115-20. doi: 10.1016/j.diabres.2004.05.009.
6
[Long-term intensive glycemic and lipid control ameliorates the carotid intima medial thickness in type 2 diabetes mellitus].长期强化血糖和血脂控制可改善2型糖尿病患者的颈动脉内膜中层厚度
Beijing Da Xue Xue Bao Yi Xue Ban. 2007 Dec 18;39(6):649-52.
7
The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.在韩国2型糖尿病患者中,餐后2小时血糖水平是颈动脉内膜中层厚度进展的独立危险因素。
J Diabetes Complications. 2007 Jan-Feb;21(1):7-12. doi: 10.1016/j.jdiacomp.2005.11.004.
8
Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients.中国 2 型糖尿病患者血清载脂蛋白 C III 水平及载脂蛋白 C III 基因 Sst I 多态性与颈动脉内膜中层厚度的相关性
Diabetes Res Clin Pract. 2004 Oct;66(1):41-7. doi: 10.1016/j.diabres.2004.02.020.
9
Effect of intensive multifactorial treatment on the intima-media thickness of large arteries in patients with new-onset type 2 diabetes mellitus.强化多因素治疗对新发 2 型糖尿病患者大动脉内-中膜厚度的影响。
J Zhejiang Univ Sci B. 2012 May;13(5):378-85. doi: 10.1631/jzus.B1100302.
10
Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus.短期强化多药联合治疗对新诊断2型糖尿病患者颈动脉内膜中层厚度的影响
Chin Med J (Engl). 2008 Apr 20;121(8):687-90.

引用本文的文献

1
Recommendations on the Clinical Use of Compound Danshen Dripping Pills.复方丹参滴丸临床应用建议
Chin Med J (Engl). 2017 Apr 20;130(8):972-978. doi: 10.4103/0366-6999.204106.